Business
CSL (ASX:CSL) share price hit by broker downgrade
The CSL Limited (ASX: CSL) share price was a positive performer on Thursday.
The biotherapeutics company’s shares charged 3% higher to end the day at $289.00.
Why did the CSL share price charge higher?
Investors were buying CSL shares following the release of a strong half year result.
For the six months ended 31 December, the company delivered a 16.9% increase in revenue over the prior corresponding period to US$5,739 million.
This was driven largely by a 38% jump in Seqirus revenue, thanks to a 44% increase in seasonal influenza vaccine sales. Demand for flu vaccines has been exceptionally strong due to the COVID-19 pandemic.
Also supporting the company’s growth was its CSL Behring business, which reported a 9% increase in…
-
Noosa News9 hours agoIf RISING’s 2025 Program Wasn’t Already Big Enough for You, Melbourne’s Winter Arts Festival Has Just Expanded Its Lineup
-
Noosa News21 hours agoLeaked live export aid plan fuels fears funding won’t help sheep farmers
-
Noosa News19 hours agoBrisbane River ‘lifestyle precinct’ finally given the green light
-
Noosa News18 hours ago‘Yes, a tablespoon’: Brooki Bakehouse owner Brooke Bellamy faces plagiarism claims over vanilla cake and other recipes